A group of patients with newly diagnosed glioma was recruited from ZNH (4 diffuse astrocytomas, IDH mutant; 2 oligodendroglioma, IDH mutant and 1p/19q codeleted; 5 glioblastoma IDH wildtype). Here, IDH2 is linked to central nervous system cancer.